75,15 €
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
impoverished and its diagnoses distorted by the Diagnostic and Statistical Manual of Mental Disorders. The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as major depression, have strayed increasingly from the real disorders of most patients. Behind
this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the
field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.
impoverished and its diagnoses distorted by the Diagnostic and Statistical Manual of Mental Disorders. The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as major depression, have strayed increasingly from the real disorders of most patients. Behind
this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the
field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.
Professor of Psychiatry, Professor of the History of Medicine, Faculty of Medicine, University of Toronto
- Preface
- PART I: GETTING GOING
- Ch 1. Introduction
- Ch 2. Before Psychopharmacology
- Ch 3. The Rise of Psychopharmacology
- Ch 4. Things Get Rolling
- Ch 5. Depression and Schizophrenia
- Ch 6. Industry: Early Days
- PART II: WORSENING
- Ch 7. DSM
- Ch 8. Science
- Ch 9. KOLs
- Ch 10. Trials Begin
- Ch 11. Trials: Fantasy Patients for Fantasy Diseases
- Ch 12. Trials: Industry Takes Over
- Ch 13. Marketing
- Ch 14. Journals
- Ch 15. FDA
- PART III: SCIENCE DISASTER
- Ch 16. Prozac and Its Cousins
- Ch 17. Sally
- Ch 18. Atypicals
- Ch 19. TMAP
- Ch 20. Fall of Psychopharmacology
- Ch 21. Conclusion
- Acknowledgments
| Erscheinungsjahr: | 2021 |
|---|---|
| Fachbereich: | Andere Fachgebiete |
| Genre: | Importe, Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Taschenbuch |
| Inhalt: | Kartoniert / Broschiert |
| ISBN-13: | 9780197574430 |
| ISBN-10: | 0197574432 |
| Sprache: | Englisch |
| Einband: | Kartoniert / Broschiert |
| Autor: | Shorter, Edward |
| Hersteller: | Oxford University Press, USA |
| Verantwortliche Person für die EU: | Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de |
| Maße: | 234 x 156 x 24 mm |
| Von/Mit: | Edward Shorter |
| Erscheinungsdatum: | 23.11.2021 |
| Gewicht: | 0,67 kg |
Ähnliche Produkte
Lieferzeit 1-2 Werktage
Aktuell nicht verfügbar
Lieferzeit 4-7 Werktage
Lieferzeit 1-2 Wochen
Lieferzeit 1-2 Wochen
